Supporting information document.

This document contains five Tables (A. Original date of activity assay of recombinant β2-AR, B. Original date of optimization of the coating buffer, C. Original date of optimization of blocking buffer, D. Original date of establishment of calibration curve, and E. Original date of recovery of β–agonist sdetermined by developed ELRA).

(DOCX)